Andrew R Robbins's Net Worth

$9.9 Million

Estimate Recalculated Sep 9, 2024 12:31AM EST

Who is Andrew R Robbins

Andrew R Robbins has an estimated net worth of $9.9 Million. This is based on reported shares across multiple companies, which include Cogent Biosciences, Inc., Harpoon Therapeutics, Inc., TURMERIC ACQUISITION CORP., and ARRAY BIOPHARMA INC.

SEC CIK

Andrew R Robbins's CIK is 0001590157

Past Insider Trading and Trends

2017 was Andrew R Robbins's most active year for acquiring shares with 8 total transactions. Andrew R Robbins's most active month to acquire stocks was the month of November. 2019 was Andrew R Robbins's most active year for disposing of shares, totalling 14 transactions. Andrew R Robbins's most active month to dispose stocks was the month of November. 2022 saw Andrew R Robbins paying a total of $3,410,808.00 for 700,167 shares, this is the most they've acquired in one year. In 2019 Andrew R Robbins cashed out on 2,044,527 shares for a total of $8,420,602.65, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cogent Biosciences, Inc.

President and CEO
Updated Jan 25, 2024
Form 4
1.10M
Jan 25, 2024
1.10M
Grant
Jan 23
Form 4
525.00K
Feb 15, 2023
525.00K
Grant
Feb 13
Form 4
690.00K
$4.94
$3.41M
Jan 27, 2022
690.00K
Grant
Jan 25
Form 4
315.20K
Feb 12, 2021
315.20K
Grant
Feb 10
Form 4
456.69K
Dec 09, 2020
456.69K
Grant
Dec 07
Form 4
7.44M
Oct 27, 2020
7.44M
Grant
Oct 23
Form 3
Oct 27, 2020
Showing 7 results

Harpoon Therapeutics, Inc.

Investor
Updated Mar 11, 2024
Form 4
-100.00%
-8.32K
Mar 11, 2024
Disposition
Mar 11
Form 4
5.00K
Nov 28, 2023
5.00K
Grant
Nov 27
Form 4
23.00K
Jun 23, 2023
23.00K
Grant
Jun 22
Form 4
10.17K
Jun 24, 2022
10.17K
Grant
Jun 22
Form 4/A
10.17K
May 14, 2021
10.17K
Grant
May 04
Form 4
10.17K
May 07, 2021
10.17K
Grant
May 04
Form 4
20.34K
Apr 01, 2020
20.34K
Grant
Mar 30
Form 3
Apr 01, 2020
Showing 8 results

TURMERIC ACQUISITION CORP.

Investor
Updated Oct 15, 2020
Form 3
Oct 15, 2020
Showing 1 results

ARRAY BIOPHARMA INC

COO
Updated Jul 30, 2019
Form 4
-100.00%
-1.65M
$48.00
Jul 30, 2019
Disposition
Jul 30
Form 4
-12.40%
-8.66K
$24.60
-$213.04K
Apr 03, 2019
80.87K
Options
Apr 01
Form 4
-76.77%
-239.63K
$12.86
-$4.09M
Feb 08, 2019
72.49K
Sale
Feb 06
Form 4
140.02%
356.48K
$15.97
-$190.01K
Dec 18, 2018
611.07K
Options
Dec 14 - Dec 16
Form 4
-16.74%
-32.07K
$18.07
-$579.61K
Jun 29, 2018
159.47K
Sale
ScheduledJun 27
Form 4
-4.62%
-8.68K
$16.32
-$141.58K
Apr 03, 2018
179.16K
Options
Apr 01
Form 4
17.80%
102.16K
$7.84
-$1.13M
Dec 19, 2017
676.17K
Sell-Options
ScheduledDec 16 - Dec 18
Form 4/A
-19.99%
-9.17K
$8.94
-$81.95K
Apr 06, 2017
36.68K
Tax
Apr 01
Form 4
-8.35%
-6.29K
$8.94
-$56.26K
Apr 04, 2017
69.09K
Options
Apr 01
Form 4
366.32K
Dec 29, 2016
366.32K
Grant
Dec 27
Form 4
691.45%
272.26K
$3.00
-$10.10K
Apr 05, 2016
311.63K
Grant
Apr 01
Form 4
325.63K
Apr 03, 2015
325.63K
Grant
Mar 02 - Apr 01
Form 4
-50.00%
-32.07K
$8.06
-$6.26K
Mar 04, 2015
32.07K
Sale
Mar 01 - Mar 02
Form 4
64.14K
Aug 20, 2014
64.14K
Grant
Aug 18
Form 4
175.00K
Apr 03, 2014
175.00K
Grant
Apr 01
Form 3
Oct 30, 2013
Showing 16 results